Page 3 - Severity Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Evaluation of autonomic dysfunction in epileptic patients during awaking & sleep in & studying association between SUDEP risk with different Holter parameters.

Orphazyme A/SCompany announcement        No. 24/2021Inside informationCompany Registration No. 32266355 Progress made in understanding potential...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Orphazyme presents 36-month data supporting durable response to arimoclomol during Parseghian ... ORPHAZYME A/SJune 28, 2021 GMT Orphazyme A/S Company Registration No. 32266355 Copenhagen – June 28, 2021 – Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company, today announced 24-month interim results of an open-label extension (OLE) trial, providing efficacy and safety data for its investigational treatment arimoclomol in Niemann-Pick disease type C (NPC) for up to 36 months. ...

DUBLIN, June 9, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc today announced that 13 abstracts sponsored by Jazz Pharmaceuticals and five abstracts from investigator-sponsored trials will be... | June 9, 2021

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 13 abstracts sponsored by Jazz Pharmaceuticals and five abstracts from...